Volume Analysis
Futures
SPOT Pivot Levels
| Type | Classic | Fibonacci |
|---|---|---|
| R1 | 2,197.13 | 2,185.29 |
| R2 | 2,220.77 | 2,198.84 |
| R3 | 2,254.53 | 2,220.77 |
| PP | 2,163.37 | 2,163.37 |
| S1 | 2,197.13 | 2,185.29 |
| S2 | 2,105.97 | 2,127.89 |
| S3 | 2,082.33 | 2,105.97 |
Ratios
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| ROCE | - | 6.96 | - | 8.65 | - |
| ROE | - | 6.15 | - | 6.57 | - |
| EPS | 10 | -26.19 | 11.7 | 5.24 | 14.66 |
Peer Comparison
| Scrip Name | Price | Daily change | M Cap | PE Ratio | 1 Year Return |
|---|
Corporate Action
- Announcements
- Board Meetings
- Dividends
- Bonus
- Splits
- Rights
- AGM/EGM
- Credit Rating
About Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets....
ISIN :INE935A01035
Registered Office
B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road
Contact number
+ 91-22-40189999
Registrars
KFin Techologies Ltd
Karvy Selenium Tow-B 31&32 Financial Dist Nanakramguda Hyderabad-500032
Karvy Selenium Tow-B 31&32 Financial Dist Nanakramguda Hyderabad-500032
Contact number
+ 91-40-67162222
Management
Glenn Saldanha (Chairman)
Glenn Saldanha (Director)
Open IPO’s
FAQs
The share price of Glenmark Pharmaceuticals Ltd on the BSE is - as on -